Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Cancer Metastatic × Interleukin-2 × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 15 Uterine Cervical Neoplasms 8 Melanoma 6 Fallopian Tube Neoplasms 6 Colorectal Neoplasms 6 Neoplasm Metastasis 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Recurrence 4 Pancreatic Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Lymphoma 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Merkel Cell 2 Carcinoma, Hepatocellular 2 Anus Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Turcot syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1

Interventions

fludarabine 1 aldesleukin 1 Interleukin-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389229 2020-12-16

OVSTAR

Immetacyte Ltd

Phase 1/2 Withdrawn

Ovarian Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡